消渴方加减联合达格列净治疗2 型糖尿病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:


Clinical Study on Modified Xiaoke Preseription Combined with Dapagliflozin for Type 2 Diabetes Mellitus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察消渴方加减联合达格列净治疗2 型糖尿病(T2DM) 气阴两虚夹瘀证的临床疗效,以及 对白细胞计数(WBC)、C-反应蛋白(CRP) 水平的影响。方法:选取102 例T2DM 气阴两虚夹瘀证患者,依 据简单随机法分为观察组与对照组各51 例。对照组给予达格列净治疗,观察组在对照组基础上联合消渴方加 减治疗,2 组均治疗2 个月。比较2 组临床疗效、中医证候积分、糖代谢指标[空腹血糖(FBG)、餐后2 h 血 糖(P2hBG)]、胰岛功能指标[空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)]、炎症指标(WBC、 CRP) 及不良反应发生率。结果:治疗后,观察组总有效率96.08%,高于对照组86.27%(P<0.05)。2 组咽 干口燥、倦怠乏力、多食易饥、口渴喜饮积分均较治疗前降低(P<0.05),观察组上述4 项中医证候积分均低 于对照组(P<0.05)。2 组FBG、P2hBG、FINS 水平及HOMA-IR 均较治疗前降低(P<0.05),观察组上述 4 项指标水平均低于对照组(P<0.05)。2 组外周血WBC、血清CRP 水平均较治疗前降低(P<0.05),观察组 外周血WBC、血清CRP 水平均低于对照组(P<0.05)。治疗期间,观察组不良反应发生率7.84%,与对照组 5.88%比较,差异无统计学意义(P>0.05)。结论:消渴方加减联合达格列净治疗T2DM 气阴两虚夹瘀证疗效 确切,可缓解患者的临床症状,改善胰岛素抵抗,降低血糖及炎症指标水平。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Xiaoke Preseription combined with Dapagliflozin for type 2 diabetes mellitus (T2DM) with deficiency of both qi and yin with stasis syndrome and its effects on the levels of white blood cell count (WBC) and C-reaction protein (CRP). Methods:A total of 102 cases of T2DM patients with deficiency of both qi and yin with stasis syndrome were selected and randomly divided into the observation group and the control group,with 51 cases in each group. The control group was treated with Dapagliflozin, and the observation group was additionally treated with modified Xiaoke Preseription based on the treatment of the control group. Both groups were treated for 2 months. Clinical effects, traditional Chinese medicine (TCM) syndrome scores, glucose metabolism indicators [fasting blood glucose (FBG),2- hour postprandial blood glucose (P2hBG)],pancreatic function indicators [fasting insulin (FINS), insulin resistance index (HOMA- IR)], inflammatory indicators (WBC, CRP), and the incidence of adverse reactions were compared between the two groups. Results:After treatment,the total effective rate was 96.08% in the observation group,higher than that of 86.27% in the control group (P<0.05). The scores of dry throat and mouth, fatigue and lack of strength, polyphagia with rapid hungering,and thirst with a desire to drink in the two groups were decreased when compared with those before treatment (P<0.05),and the above four TCM syndrome scores in the observation group were lower than those in the control group (P<0.05). The levels of FBG, P2hGB, FINS, and HOMA- IR in the two groups were decreased when compared with those before treatment (P<0.05), and the levels of above four indicators in the observation group were lower than those in the control group (P<0.05). The levels of WBC in peripheral blood and CRP in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of above two indexes in the observation group were lower than those in the control group (P<0.05). During treatment,the incidence of adverse reactions was 7.84% in the observation group and 5.88% in the control group, and there was no significant difference in the comparison (P>0.05). Conclusion:Modified Xiaoke Preseription combined with Dapagliflozin has a definite curative effect in the treatment of T2DM with deficiency of both qi and yin with stasis syndrome,and can relieve clinical symptoms, improve insulin resistance, and reduce the levels of blood glucose and inflammatory indicators.

    参考文献
    相似文献
    引证文献
引用本文

金徐燕,童海航,谢妙时.消渴方加减联合达格列净治疗2 型糖尿病临床研究[J].新中医,2024,56(2):79-83

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-01-25
  • 出版日期:
文章二维码